Pathogenesis of Monoclonal Gammopathy of Undetermined Significance and Progression to Multiple Myeloma
- 31 January 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 48 (1), 4-12
- https://doi.org/10.1053/j.seminhematol.2010.11.003
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- The significance of monoclonal gammopathy of undetermined significanceHaematologica, 2009
- Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic contextHaematologica, 2009
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewLeukemia, 2009
- Centrosomes and myeloma; Aneuploidy and proliferationEnvironmental and Molecular Mutagenesis, 2009
- DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significanceAnnals of Hematology, 2009
- Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in SwedenBlood, 2009
- A monoclonal gammopathy precedes multiple myeloma in most patientsBlood, 2009
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisProceedings of the National Academy of Sciences of the United States of America, 2008
- Clinical and biological significance of RAS mutations in multiple myelomaLeukemia, 2008